Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Pulsed radiofrequency to femoral and obturator nerve branches for hip pain

Official title: A Study on the Effectiveness of Pulsed Radiofrequency Treatment Applied to the Femoral and Obturator Nerve Articular Branches Under Ultrasound Guidance in Chronic Hip Osteoarthritis

Run by Diskapi Teaching and Research Hospital · NCT07190339 · Data updated 2026-11-12

This trial will try ultrasound-guided pulsed radiofrequency on the femoral and obturator nerve branches to reduce hip and groin pain and improve function in people with hip osteoarthritis who have not improved with medicines and physical therapy.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorDiskapi Teaching and Research Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Ankara)
StatusRecruiting
StartedSeptember 20, 2025
Main results expectedApril 20, 2026
Study endsAugust 20, 2026
Registry record updatedSeptember 30, 2025
Trial IDNCT07190339 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with radiographic hip osteoarthritis who have had hip or groin pain greater than VAS 5 for more than six weeks and who did not respond to analgesics and physical therapy are ideal candidates.

Probably not a fit

Patients with lumbar radiculopathy, axial back pain, sacroiliac joint disease, connective tissue disorders, recent additional analgesic or interventional procedures, or inability to attend follow-up are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional, single-site study applies ultrasound-guided pulsed radiofrequency (pRF) to the articular branches of the femoral and obturator nerves in patients with chronic hip pain from osteoarthritis. Participants who failed conservative care and have significant pain will receive the procedure and be followed at 2, 6, and 12 weeks. Outcomes include pain measured by the Numeric Rating Scale (NRS) and function measured by the Oxford Hip Score (OHS). The procedure is performed without radiation and is intended as a minimally invasive option to reduce pain and improve mobility.

Why it matters

Potential benefit: If successful, the procedure could reduce hip and groin pain and improve function, potentially delaying or avoiding joint replacement for some patients.

How similar studies have gone: Thermal radiofrequency neurolysis of target nerves has shown positive pain relief but carries risk of neuritis and neuroma, while pulsed radiofrequency to these articular branches is a newer, less destructive approach with limited but encouraging preliminary data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Patients with hip and groin pain who have been diagnosed with hip osteoarthritis by direct radiography
* 2\. Patients who have had hip pain above VAS 5 for more than 6 weeks
* 3\. Failure of pain treatment with conservative methods such as analgesics and physical therapy

Exclusion Criteria:

* 1\. Patients with lumbar radiculopathy and axial back pain, sacroiliac joint, connective tissue disease
* 2\. Patients who do not attend follow-up appointments regularly or cannot be reached by phone
* 3\. Patients who started additional analgesic medication or underwent additional interventional procedures after the initial interventional procedure

Where it's running

  • Ankara Etlik City Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.